Interviews

Tom Deitrich

2025-11-06

Today, the pace has changed. Our current generation solutions operate more like a smartphone, where the utility can download applications to endpoints and take actions at the edge—bringing software to problems that once required digging up streets or over-building infrastructure.

Alexandre de Vigan

Founder & CEO

Nfinite

2025-11-05

When we founded Nfinite, the vision was clear: digitize the world in 3D.

Kirk Coleman

Chief Business Officer

2025-11-05

Access is undeniably better, but equal outcomes are nowhere near guaranteed.

Jon R. Cohen

CEO

Talkspace

2025-11-03

We’re building what we call a “safe model” — an AI therapy agent that’s clinically sound, risk-aware, and supervised by real therapists. Once fully developed, it could provide safe, immediate support to people who currently lack access to care. Imagine every university student having a personal AI therapy companion that can detect distress and seamlessly connect them with professional help when needed.

Antonio Delgado

CEO

Natac

2025-11-03

We want to consolidate growth, but above all, we are proud of our people and our culture. From four people 15 years ago, we are now more than 180. The challenge is to maintain the team spirit and culture as we grow.

Dr. Martin Tolar

President & CEO

Alzheon

2025-11-03

Our data suggests that treatment with valiltramiprosate at earliest symptomatic stage (MCI) can stabilize patients for years, allowing them to remain functional and independent much longer. We have seen this in multiple clinical studies showing consistent clinical benefits on both cognition and function. Translating this into practice could mean delaying the disability and loss of independence that leads to nursing home placement by almost a decade, which would have a profound impact on patients, their families, and healthcare systems alike.

Carl Gordon

Managing Partner

OrbiMed Advisors

2025-10-29

I think it’s an exciting time for the sector. It’s never easy to be a biotech investor, but over the last several months, the climate has improved significantly. The XBI index is a good indicator—it’s now just over 100, up from the high 60s at its lowest point. That’s roughly a 50% increase from the trough. So yes, I do believe we’ve turned a corner in biotech for a number of reasons.

Punit Soni

CEO & Co-Founder

Suki AI

2025-10-28

Our focus is user love and consistent quality across that complexity. We have plenty of demand; the constraint is serving it flawlessly. Even though we believe we still have more to do to reach the quality bar we set for ourselves.

Lewis Black

Director, President & CEO

Almonty Industries

2025-10-27

A military jet loaded with rare-earth magnets cannot leave the hangar without tungsten

Jorge A. Ganoza

CEO

Fortuna Mining Corp.

2025-10-27

As a gold-silver producer we focus on chasing value rather than ounces, investing through the cycle because no one can time the market perfectly.

Pagina 12 din 212